Beta blockade in the treatment of autonomic dysreflexia: a case report and review.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9596403.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Autonomic dysreflexia has long been considered a sympathetically mediated phenomenon. Recent articles have reported the use of alpha blockers as a means of treatment. We report the case of a 20-year-old C5 American Spinal Injury Association A spinal cord injured patient who almost daily experienced symptoms of headache, facial flushing, and hypertension consistent with autonomic dysreflexia. These symptoms caused him frequent discomfort and anxiety. Despite an extensive workup, we were unable to identify a source of his dysreflexic episodes. After starting metoprolol 50 mg every night, however, these episodes stopped and the patient showed no adverse effects from the medication.
Medical subject headings
- Adrenergic beta-Antagonists
- Autonomic Nervous System Diseases
- Cervical Vertebrae
- Metoprolol
- Spinal Cord Injuries
- Spinal Fractures
Anatomy
- cervical spine